Table 2 Demographical and clinical characteristics of 101 diabetic foot patients with necrotizing fasciitis
Variables | Number (%) |
|---|---|
Male | 67 (66.3%) |
Female | 34 (33.7%) |
Age | 60.32 ± 11.62 |
Type 1 Diabetes | 3 (3.0%) |
Type 2 Diabetes | 98 (97.0%) |
The duration of diabetes, years | 10.27 ± 7.09 |
Blood Glucose (mmol/l) | 16.37 ± 6.29 |
HbA1c (%)  ≤ 7% (good control) | 11.46 ± 2.79 6 (5.8%) |
Hospital stays, days | 30.17 ± 21.93 |
Duration of the ulcer, days | |
 30 days or less | 76 (75.2%) |
 Over 30 days | 25 (24.8%) |
The type of insulin | |
 Pre-mixed insulins | 22 (21.8%) |
 Intermediate-acting insulin (NPH) | 7 (6.9%) |
 Rapidly acting insulin analogs + Basal insulin analogs | 5 (5.0%) |
 Rapidly acting insulin analogs | 3 (3.0%) |
 Basal insulin analogs | 2 (2.0%) |
 Rapidly acting insulin analogs + NPH | 1 (1.0%) |
 Type of insulin was not known | 4 (4.0%) |
Location of foot ulcers | |
 Planta | 31 |
 Foot dorsum | 20 |
 Hallux | 17 |
 The second phalanx | 14 |
 The third phalanx | 10 |
 The fourth phalanx | 9 |
 The fifth phalanx | 26 |
 Others | 19 |
Concomitant disease | |
 Hypertension | 46 (45.5%) |
 Anemia | 26 (25.7%) |
 Hypoproteinemia | 25 (24.8%) |
 Osteoporosis | 20 (19.8%) |
 Lower extremity atherosclerotic occlusive disease | 18 (17.8%) |
Complications | |
 Neuropathy | 95 (94.1%) |
 Lower extremity vascular disease | 49 (48.5%) |
 Nephropathy | 43 (42.6%) |
 Retinopathy | 54 (53.5%) |
The amputation rate | 32 (31.7%) |
Antibiotics use before admission | 73 (72.3%) |